<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/6A125DBF-5556-4101-94D4-51E12992F058"><gtr:id>6A125DBF-5556-4101-94D4-51E12992F058</gtr:id><gtr:name>UC Davis School of Medicine</gtr:name><gtr:address><gtr:line1>UC Davis School of Medicine</gtr:line1><gtr:line2>4610 X Street</gtr:line2><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/0FED1C47-231B-46E3-9C8D-2CE5528F10B1"><gtr:id>0FED1C47-231B-46E3-9C8D-2CE5528F10B1</gtr:id><gtr:name>The Karolinska Institute, Stockholm</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/091A7281-194A-4C7B-8E9A-0CEB4FEE954B"><gtr:id>091A7281-194A-4C7B-8E9A-0CEB4FEE954B</gtr:id><gtr:name>Faculty of Medicine</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/C842A34F-18F7-454D-A259-FED802368496"><gtr:id>C842A34F-18F7-454D-A259-FED802368496</gtr:id><gtr:name>University of Leicester</gtr:name><gtr:department>Genetics</gtr:department><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Leicester</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE1 7RH</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/C842A34F-18F7-454D-A259-FED802368496"><gtr:id>C842A34F-18F7-454D-A259-FED802368496</gtr:id><gtr:name>University of Leicester</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Leicester</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE1 7RH</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/6A125DBF-5556-4101-94D4-51E12992F058"><gtr:id>6A125DBF-5556-4101-94D4-51E12992F058</gtr:id><gtr:name>UC Davis School of Medicine</gtr:name><gtr:address><gtr:line1>UC Davis School of Medicine</gtr:line1><gtr:line2>4610 X Street</gtr:line2><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/0FED1C47-231B-46E3-9C8D-2CE5528F10B1"><gtr:id>0FED1C47-231B-46E3-9C8D-2CE5528F10B1</gtr:id><gtr:name>The Karolinska Institute, Stockholm</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/091A7281-194A-4C7B-8E9A-0CEB4FEE954B"><gtr:id>091A7281-194A-4C7B-8E9A-0CEB4FEE954B</gtr:id><gtr:name>Faculty of Medicine</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/48EF19F1-5BA9-4436-BB4E-483C6F0F1EE4"><gtr:id>48EF19F1-5BA9-4436-BB4E-483C6F0F1EE4</gtr:id><gtr:firstName>Edward</gtr:firstName><gtr:surname>Hollox</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0801123"><gtr:id>D851F31F-161F-4C4C-B112-EBDEA2C019A7</gtr:id><gtr:title>Relationship between copy number variation in innate immunity genes and infectious disease</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0801123</gtr:grantReference><gtr:abstractText>Humans normally have two copies of every gene: one from their mother and one from their father. However, copy number variation, where different individuals have different numbers of the same gene, is more common than previously thought. This variation between people affects susceptibility to common diseases such as psoriasis. In this project, we will investigate copy number variation of three genes that are part of the body?s defence against bacteria and viruses. We will test if people with tuberculosis or AIDS have different numbers of these genes compared to healthy people. This will give clues on the importance of these genes involved in infection. It could also potentially identify drug targets for future work.</gtr:abstractText><gtr:technicalSummary>Recent work has suggested that copy number variation (CNV) is more common in the human genome than previously thought, and up to 12% of the genome may show CNV. Innate immunity genes are over-represented in regions in the genome that have been identified as showing CNV, therefore variation in gene dosage of innate immunity genes is likely to be a significant component of the total genetic variability in susceptibility to infectious disease. Our aim is to develop assays for three genomic regions that contains genes of the innate immune system and show CNV. They have been chosen as especially good candidates for involvement in HIV and tuberculosis infection. We will test how their variation affects susceptibility and severity of HIV-1 infection and tuberculosis by typing an African case-control cohort for CNV and selected sequence variation within the CNV. Any significant associations will be further tested on a further African and/or Chinese case-control cohort.</gtr:technicalSummary><gtr:fund><gtr:end>2012-03-31</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-04-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>315826</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>UC Davis School of Medicine</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Department of Medical Microbiology and Immunology</gtr:department><gtr:description>UC Davis infertility DEFB126</gtr:description><gtr:id>1A0CC2E6-A779-46F9-9D12-2A7DB8DD64A4</gtr:id><gtr:impact>Science Translational Medicien paper (July 2011). This is a multi-disciplinary collaboration, involving immunologists, human geneticists (us), clinician scientists and reproductive biologists.</gtr:impact><gtr:piContribution>We developed a genotyping assay for the common DEFB126 deletion, inestigated variation at this gene further, and contributed to data analysis.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Karolinska Institute</gtr:collaboratingOrganisation><gtr:country>Sweden, Kingdom of</gtr:country><gtr:department>Division of Clinical Pharmacology</gtr:department><gtr:description>Aklillu HIV</gtr:description><gtr:id>16FA4009-88A9-4A58-9905-E736A6BFEB8F</gtr:id><gtr:impact>Journal of Infectious Diseases paper</gtr:impact><gtr:partnerContribution>Provision of samples and clinical information from African cohorts</gtr:partnerContribution><gtr:piContribution>Analysis of HIV cohorts for CNV loci</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Faculty of Medicine</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Medicine</gtr:department><gtr:description>Vyse - Imperial</gtr:description><gtr:id>F6EF5AA5-F7BF-4081-A0BE-81E754191D73</gtr:id><gtr:impact>Research paper in Human Mutation</gtr:impact><gtr:partnerContribution>Supply of DNA material and genotype information to support research</gtr:partnerContribution><gtr:piContribution>Joint development of a accurate assay for typing complement C4 gene copy number. I hosted a member of Prof Vyse's team for several days where we developed the details of a new assay for a key biological problem in the Imperial lab.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Public GENIE lecture</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>EDBC6578-F9C6-49B5-8839-7B2AFDF9D34A</gtr:id><gtr:impact>40 members of the public (including approxiamately 20 6th formers) attended a public lecture organised by GENIE, the teaching and outreach resource centre in the University.

The presentation was very well recieved by a teacher in a local sixth-form college, who has asked for the presentation to be on the web as a resource for her and her students.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Royal Society Summer Science Exhibition</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>1E76BF79-128F-4705-84F0-1D0C0A3A152D</gtr:id><gtr:impact>I was involved in developing exhibits for, and presenting at, the Royal Society Summer Science Exhibition, on genetic aspects of lung disease. Over 11,000 people attended this exhibition, including 1452 students and 193 teachers. The exhibit was covered by major daily newspapers, Time Out, and the BBC. The website url for our exhibit is http://sse.royalsociety.org/2012/exhibits/breathless-genes/


The printed human genome, which I generated as part of this exhibition, will be on display from 26th March to 31st November as part of the Inside DNA exhibition at Leicester's New Walk Museum.</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>563153</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Pfizer Contract Grant</gtr:description><gtr:end>2013-11-02</gtr:end><gtr:fundingOrg>Pfizer Ltd</gtr:fundingOrg><gtr:id>D926E59F-9F07-42FA-A15E-D5BEE4694287</gtr:id><gtr:sector>Private</gtr:sector><gtr:start>2011-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>5500</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EMBO Short Term Travel Fellowship (second)</gtr:description><gtr:end>2012-06-02</gtr:end><gtr:fundingOrg>European Molecular Biology Organisation (EMBO)</gtr:fundingOrg><gtr:id>A1A15C53-81DA-4561-876E-D404CFE16344</gtr:id><gtr:sector>Learned Society</gtr:sector><gtr:start>2012-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>338747</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Project Grant (Mutation and diversity in copy number variable genes)</gtr:description><gtr:end>2013-01-02</gtr:end><gtr:fundingOrg>The Wellcome Trust Ltd</gtr:fundingOrg><gtr:id>8DEB7C58-59DD-4ED1-825F-979089461469</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EMBO Short Term Travel Fellowship</gtr:description><gtr:end>2010-06-02</gtr:end><gtr:fundingOrg>European Molecular Biology Organisation (EMBO)</gtr:fundingOrg><gtr:id>C3BB9BFE-13ED-4372-A2FE-6B89C59F0836</gtr:id><gtr:sector>Learned Society</gtr:sector><gtr:start>2010-03-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CD747AA6-49AA-42CC-A0E8-25120B3DE550"><gtr:id>CD747AA6-49AA-42CC-A0E8-25120B3DE550</gtr:id><gtr:title>Copy-number variation of the neuronal glucose transporter gene SLC2A3 and age of onset in Huntington's disease.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8d61dac223e86505678cc21f7cceac5e"><gtr:id>8d61dac223e86505678cc21f7cceac5e</gtr:id><gtr:otherNames>Vittori A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/103EB944-951A-400C-B31C-E4C41F09764A"><gtr:id>103EB944-951A-400C-B31C-E4C41F09764A</gtr:id><gtr:title>?-defensin genomic copy number is associated with HIV load and immune reconstitution in sub-saharan Africans.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6bd6156f4d6631e78d7a4bf4541d33ea"><gtr:id>6bd6156f4d6631e78d7a4bf4541d33ea</gtr:id><gtr:otherNames>Hardwick RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BFEE9656-5E7B-4CF7-89BE-AB9792FD84D4"><gtr:id>BFEE9656-5E7B-4CF7-89BE-AB9792FD84D4</gtr:id><gtr:title>Evidence of convergent evolution in humans and macaques supports an adaptive role for copy number variation of the ?-defensin-2 gene.</gtr:title><gtr:parentPublicationTitle>Genome biology and evolution</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/93e8c1fb67851c3a294325a3ce4d8d2e"><gtr:id>93e8c1fb67851c3a294325a3ce4d8d2e</gtr:id><gtr:otherNames>Ottolini B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1759-6653</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0E77B4B8-A67F-4D65-BCF6-0DC5E5E7A9D1"><gtr:id>0E77B4B8-A67F-4D65-BCF6-0DC5E5E7A9D1</gtr:id><gtr:title>Human gene copy number variation and infectious disease.</gtr:title><gtr:parentPublicationTitle>Human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5d18df362fff6bd2646bc1a5f36838c1"><gtr:id>5d18df362fff6bd2646bc1a5f36838c1</gtr:id><gtr:otherNames>Hollox EJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0340-6717</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A84DDA54-E69E-47DA-AFF1-0792E329B6AB"><gtr:id>A84DDA54-E69E-47DA-AFF1-0792E329B6AB</gtr:id><gtr:title>?-Defensin Genomic Copy Number Does Not Influence the Age of Onset in Huntington's Disease.</gtr:title><gtr:parentPublicationTitle>Journal of Huntington's disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8d61dac223e86505678cc21f7cceac5e"><gtr:id>8d61dac223e86505678cc21f7cceac5e</gtr:id><gtr:otherNames>Vittori A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1879-6397</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8ADA1016-1E53-4358-9ED3-665929BE4907"><gtr:id>8ADA1016-1E53-4358-9ED3-665929BE4907</gtr:id><gtr:title>Automated design of paralogue ratio test assays for the accurate and rapid typing of copy number variation.</gtr:title><gtr:parentPublicationTitle>Bioinformatics (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/549c31438a6ac49a51f15ae0dec71a33"><gtr:id>549c31438a6ac49a51f15ae0dec71a33</gtr:id><gtr:otherNames>Veal CD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1367-4803</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5B3D3F17-DE4C-4680-BA6E-F6E32ABF9EAF"><gtr:id>5B3D3F17-DE4C-4680-BA6E-F6E32ABF9EAF</gtr:id><gtr:title>Expansion of a 12-kb VNTR containing the REXO1L1 gene cluster underlies the microscopically visible euchromatic variant of 8q21.2.</gtr:title><gtr:parentPublicationTitle>European journal of human genetics : EJHG</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c78770060b2db6aab9c5378467309154"><gtr:id>c78770060b2db6aab9c5378467309154</gtr:id><gtr:otherNames>Tyson C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1018-4813</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/496A3D2B-168E-4206-9DFD-D965A1D2FDE8"><gtr:id>496A3D2B-168E-4206-9DFD-D965A1D2FDE8</gtr:id><gtr:title>Detection of copy number changes in DNA from formalin fixed paraffin embedded tissues using paralogue ratio tests.</gtr:title><gtr:parentPublicationTitle>Analytical chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3f722cf5e1d220ed569e03e3fe9016ae"><gtr:id>3f722cf5e1d220ed569e03e3fe9016ae</gtr:id><gtr:otherNames>Saldanha G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0003-2700</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9E2384E6-8CD7-4CB2-9C79-B1B95669122A"><gtr:id>9E2384E6-8CD7-4CB2-9C79-B1B95669122A</gtr:id><gtr:title>Determination of beta-defensin genomic copy number in different populations: a comparison of three methods.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/35d92552438d4b8413cb36581e6e6a48"><gtr:id>35d92552438d4b8413cb36581e6e6a48</gtr:id><gtr:otherNames>Fode P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/89874825-2B93-4786-9FF1-0609A5E7DFE9"><gtr:id>89874825-2B93-4786-9FF1-0609A5E7DFE9</gtr:id><gtr:title>Copy number variation of the beta defensin gene cluster on chromosome 8p influences the bacterial microbiota within the nasopharynx of otitis-prone children.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/219fd365c65c8e5453abf364f3b950a6"><gtr:id>219fd365c65c8e5453abf364f3b950a6</gtr:id><gtr:otherNames>Jones EA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A27D66A8-E078-44EA-B741-9792D05DE288"><gtr:id>A27D66A8-E078-44EA-B741-9792D05DE288</gtr:id><gtr:title>Assessment of complement C4 gene copy number using the paralog ratio test.</gtr:title><gtr:parentPublicationTitle>Human mutation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/49bd67d807d83351b6bc96cd76bfa75b"><gtr:id>49bd67d807d83351b6bc96cd76bfa75b</gtr:id><gtr:otherNames>Fernando MM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1059-7794</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3BA8132B-C542-4FF2-8292-496AD719E6EA"><gtr:id>3BA8132B-C542-4FF2-8292-496AD719E6EA</gtr:id><gtr:title>?-Defensin genomic copy number does not influence the age of onset in Huntington's Disease.</gtr:title><gtr:parentPublicationTitle>Journal of Huntington's disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8d61dac223e86505678cc21f7cceac5e"><gtr:id>8d61dac223e86505678cc21f7cceac5e</gtr:id><gtr:otherNames>Vittori A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1879-6397</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/602CEC7F-69EF-48C8-8705-A48FFF9F9BE4"><gtr:id>602CEC7F-69EF-48C8-8705-A48FFF9F9BE4</gtr:id><gtr:title>Evolutionary genetics of the human Rh blood group system.</gtr:title><gtr:parentPublicationTitle>Human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b0c42f45df510586c84673b68c8ac846"><gtr:id>b0c42f45df510586c84673b68c8ac846</gtr:id><gtr:otherNames>Perry GH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0340-6717</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C7C532DA-2EFA-4A45-ACA6-18B07DF3FAAB"><gtr:id>C7C532DA-2EFA-4A45-ACA6-18B07DF3FAAB</gtr:id><gtr:title>A common mutation in the defensin DEFB126 causes impaired sperm function and subfertility.</gtr:title><gtr:parentPublicationTitle>Science translational medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4b5f7c2b491bdef2107e5df5de498b8c"><gtr:id>4b5f7c2b491bdef2107e5df5de498b8c</gtr:id><gtr:otherNames>Tollner TL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1946-6234</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A2B71D71-A813-4ABF-8BFB-CF2022CC060F"><gtr:id>A2B71D71-A813-4ABF-8BFB-CF2022CC060F</gtr:id><gtr:title>Copy number variation of the beta-defensin genes in europeans: no supporting evidence for association with lung function, chronic obstructive pulmonary disease or asthma.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a94bd817e0697ab1ede1ac552afec188"><gtr:id>a94bd817e0697ab1ede1ac552afec188</gtr:id><gtr:otherNames>Wain LV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/843CE4F7-BF47-415C-BFA9-7AD5014E2F56"><gtr:id>843CE4F7-BF47-415C-BFA9-7AD5014E2F56</gtr:id><gtr:title>Haptoglobin (HP) and Haptoglobin-related protein (HPR) copy number variation, natural selection, and trypanosomiasis.</gtr:title><gtr:parentPublicationTitle>Human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6bd6156f4d6631e78d7a4bf4541d33ea"><gtr:id>6bd6156f4d6631e78d7a4bf4541d33ea</gtr:id><gtr:otherNames>Hardwick RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0340-6717</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7B71DC40-ED30-4501-A995-02517ED25CDD"><gtr:id>7B71DC40-ED30-4501-A995-02517ED25CDD</gtr:id><gtr:title>A worldwide analysis of beta-defensin copy number variation suggests recent selection of a high-expressing DEFB103 gene copy in East Asia.</gtr:title><gtr:parentPublicationTitle>Human mutation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6bd6156f4d6631e78d7a4bf4541d33ea"><gtr:id>6bd6156f4d6631e78d7a4bf4541d33ea</gtr:id><gtr:otherNames>Hardwick RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1059-7794</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0801123</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>